Found 9693 bookmarks
Newest
Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease - PubMed
Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease - PubMed
Rates of CDI among hospitalized patients with IBD had initially increased, but have declined since 2015. Increased comorbidity, large hospital size, public insurance, and urban teaching hospitals were associated with higher rates of CDI. CDI was associated with increased mortality in hospitalized pa …
·pubmed.ncbi.nlm.nih.gov·
Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease - PubMed
Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo - PubMed
Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo - PubMed
Clostridioides difficile is a leading cause of antibiotic-associated diarrhea and nosocomial infection in the United States. The symptoms of C. difficile infection (CDI) are associated with the production of two homologous protein toxins, TcdA and TcdB. The toxins are considered bona fide targets fo …
·pubmed.ncbi.nlm.nih.gov·
Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo - PubMed
Gut Microbiota Regulates Epigenetic Remodelling in the Amygdala: A Role in Repeated Mild Traumatic Brain Injury (rMTBI)-Induced Anxiety - PubMed
Gut Microbiota Regulates Epigenetic Remodelling in the Amygdala: A Role in Repeated Mild Traumatic Brain Injury (rMTBI)-Induced Anxiety - PubMed
Gut microbiota serves in the development and maintenance of phenotype. However, the underlying mechanisms are still in its infancy. The current study shows epigenetic remodelling in the brain as a causal mechanism in the gut microbiota-brain axis. Like in trauma patients, gut dysbiosis and anxiety w …
·pubmed.ncbi.nlm.nih.gov·
Gut Microbiota Regulates Epigenetic Remodelling in the Amygdala: A Role in Repeated Mild Traumatic Brain Injury (rMTBI)-Induced Anxiety - PubMed
Core genome multilocus sequence typing of Clostridioides difficile to investigate transmission in the hospital setting - PubMed
Core genome multilocus sequence typing of Clostridioides difficile to investigate transmission in the hospital setting - PubMed
Among clusters determined by cgMLST analysis, roughly 40% included unexplained HA-CDI acquisitions, which may be explained by unidentified epidemiological links, asymptomatic colonization, and/or shared common community reservoirs. The use of DLST, followed by whole genome sequencing analysis, is a …
·pubmed.ncbi.nlm.nih.gov·
Core genome multilocus sequence typing of Clostridioides difficile to investigate transmission in the hospital setting - PubMed
Match preview | Imps vs Charlton Athletic
Match preview | Imps vs Charlton Athletic
The Imps will aim for back-to-back Sky Bet League One wins when hosting Charlton Athletic on Tuesday 24 October (7.45pm KO).
·news.google.com·
Match preview | Imps vs Charlton Athletic
VIDEO: Rebyota ‘not only shuts down recurrence,’ also affects quality of life in C. diff
VIDEO: Rebyota ‘not only shuts down recurrence,’ also affects quality of life in C. diff
VANCOUVER, British Columbia — In this Healio video, Paul Feuerstadt, MD, FACG, AGAF, discusses data that link health-related quality of life and microbiome composition among patients with recurrent Clostridioides difficile infection. “C. difficile is a major problem in the United States; in fact, it’s estimated that upwards of a half million individuals are diagnosed with this
·news.google.com·
VIDEO: Rebyota ‘not only shuts down recurrence,’ also affects quality of life in C. diff
Colonic distribution of FMT by different enema procedures compared to colonoscopy – proof of concept study using contrast fluid - BMC Gastroenterology
Colonic distribution of FMT by different enema procedures compared to colonoscopy – proof of concept study using contrast fluid - BMC Gastroenterology
Background Fecal microbiota transplantation (FMT) has become an important treatment method in recurrent Clostridioides difficile infections and is under investigation as a treatment for several other diseases. FMT’s mechanism of action is assumed to be through alterations of the colon microbiota. FMT can be delivered by several methods, but few studies have directly compared how FMT is distributed in the colon by different methods. Specifically, the proximal distribution of FMT delivered by enema is unknown. Methods In eight participants, we administered contrast fluid (CF) with viscosity similar to an FMT in a crossover study design. First, CF was administered by colonoscopy, followed by an abdominal X-ray to visualize the CF distribution. Next, after four to eight weeks, participants were given CF, but as an enema, followed by a positioning procedure. X-rays were obtained before (enema ÷) and after (enema +) the positioning procedure. Conclusion Proportion of participants with CF in cecum were 100% after colonoscopy, 50% after enema + and 38% after enema ÷. In the transverse colon, proportions were 100% (colonoscopy), 88% (enema +) and 63% (enema ÷). There were no adverse events. Interpretation This study shows proof of concept for the distribution of FMT to proximal colon when delivered by enema. A positioning procedure after the enema slightly improves the proximal distribution. However, colonoscopy is the only method that ensures delivery to the cecum. Studies are needed to see if FMT colon distribution correlates with treatment effectiveness. Trial registration The study was retrospectively registered at ClinicalTrials.gov (NCT05121285) (16/11/2021).
·news.google.com·
Colonic distribution of FMT by different enema procedures compared to colonoscopy – proof of concept study using contrast fluid - BMC Gastroenterology
Gut microbiota and traumatic central nervous system injuries: Insights into pathophysiology and therapeutic approaches - PubMed
Gut microbiota and traumatic central nervous system injuries: Insights into pathophysiology and therapeutic approaches - PubMed
Traumatic brain injury and spinal cord injury are two distinct but fundamentally similar types of acute insults to the central nervous system (CNS) that often culminate in death or cognitive and motor impairment. Over the past decade, researchers have tapped into research to discover the potential r …
·pubmed.ncbi.nlm.nih.gov·
Gut microbiota and traumatic central nervous system injuries: Insights into pathophysiology and therapeutic approaches - PubMed
Fecal microbiota transplant for treatment of diarrhea in adult hospitalized horses-111 cases (2013-2018) - PubMed
Fecal microbiota transplant for treatment of diarrhea in adult hospitalized horses-111 cases (2013-2018) - PubMed
There were no significant advantages of performing FMTs in horses with diarrhea in this retrospective study. This highlights the need for prospective, randomized studies to evaluate the efficacy of FMT, as well as different formulations, in horses with colitis before this can become standard practic …
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplant for treatment of diarrhea in adult hospitalized horses-111 cases (2013-2018) - PubMed
Gut Microbiome (Bacteria, Fungi, and Viruses) and HIV Infection: Revealing Novel Treatment Strategies - PubMed
Gut Microbiome (Bacteria, Fungi, and Viruses) and HIV Infection: Revealing Novel Treatment Strategies - PubMed
Plenty of research on microbial-viral interactions has revealed that some commensal microorganisms in the gut, including bacteria, fungi, and viruses, can resist or promote viral infection, whereas other microorganisms are involved in pathogenicity. Therefore, the balance between commensal microorga …
·pubmed.ncbi.nlm.nih.gov·
Gut Microbiome (Bacteria, Fungi, and Viruses) and HIV Infection: Revealing Novel Treatment Strategies - PubMed
Global Microbiome Therapeutics for Clostridium Difficile Infection Market is projected to reach the value of USD 3.75 billion by 2030
Global Microbiome Therapeutics for Clostridium Difficile Infection Market is projected to reach the value of USD 3.75 billion by 2030
According to the report published by Virtue Market Research in Global Microbiome Therapeutics for Clostridium Difficile Infection Market was valued at USD 1 2 billion and is projected to reach a market size of USD 3 75 billion by the ...
·news.google.com·
Global Microbiome Therapeutics for Clostridium Difficile Infection Market is projected to reach the value of USD 3.75 billion by 2030
Re: 'the effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et al - PubMed
Re: 'the effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et al - PubMed
Re: 'the effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et al
·pubmed.ncbi.nlm.nih.gov·
Re: 'the effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et al - PubMed
C difficile and antibiotics . . . and other stories
C difficile and antibiotics . . . and other stories
A case-control study from the US quantified the risk of Clostridioides difficile infection following a recent antibiotic prescription. It found a 20-fold variation across antibiotic classes and only slightly less variation across individual antibiotics within classes. Clindamycin and later generation cephalosporins carried the greatest risk for C difficile infection, while tetracyclines hardly increased risk at all ( Open Forum Infect Dis doi:10.1093/ofid/ofad413). People who said they were lonely at the time of recruitment into the UK Biobank study were more likely to develop incident Parkinson disease over 15 years of observation. The association was only slightly diminished after adjustment …
·news.google.com·
C difficile and antibiotics . . . and other stories
Acurx Announces Ibezapolstat Scientific Posters and Presentations at ClostPath 2023 and IDWeek 2023 Scientific Conferences
Acurx Announces Ibezapolstat Scientific Posters and Presentations at ClostPath 2023 and IDWeek 2023 Scientific Conferences
Acurx Pharmaceuticals, Inc. today announced three scientific posters were presented during the 13th International Conference on Molecular Biology and Pathogenesis of Clostridia (ClostPath) held in Banff, Canada from September 19 to 23, 2023.
·biospace.com·
Acurx Announces Ibezapolstat Scientific Posters and Presentations at ClostPath 2023 and IDWeek 2023 Scientific Conferences
An epidemiological surveillance study (2021-2022): detection of a high diversity of Clostridioides difficile isolates in one tertiary hospital in Chongqing, Southwest China - PubMed
An epidemiological surveillance study (2021-2022): detection of a high diversity of Clostridioides difficile isolates in one tertiary hospital in Chongqing, Southwest China - PubMed
The strains identified in Chongqing, Southwest China, exhibited high genetic diversity. Enhance full awareness of high-risk patients with HA-CDI infection, particularly those with gastrointestinal and hepatocellular diseases, and emphasize caution in the use of tetracycline and capecitabine. These f …
·pubmed.ncbi.nlm.nih.gov·
An epidemiological surveillance study (2021-2022): detection of a high diversity of Clostridioides difficile isolates in one tertiary hospital in Chongqing, Southwest China - PubMed
C. Diff: What It Is, Causes, Symptoms & Treatment
C. Diff: What It Is, Causes, Symptoms & Treatment
C. diff (Clostridioides difficile) is bacteria that causes about 500,000 infections a year in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC). It can have mild to severe health consequences.Discover what C. diff infection is, how you get it, and its symptoms...
·news.google.com·
C. Diff: What It Is, Causes, Symptoms & Treatment
Polyamines and hypusination are important for Clostridioides difficile toxin B (TcdB)-mediated activation of group 3 innate lymphocytes (ILC3s) - PubMed
Polyamines and hypusination are important for Clostridioides difficile toxin B (TcdB)-mediated activation of group 3 innate lymphocytes (ILC3s) - PubMed
Clostridioides difficile is the most common cause of nosocomial gastrointestinal tract bacterial infections. We lack fully effective reliable treatments for this pathogen, and there is a critical need to better understand how C. difficile interacts with our immune system. Group 3 innat …
·pubmed.ncbi.nlm.nih.gov·
Polyamines and hypusination are important for Clostridioides difficile toxin B (TcdB)-mediated activation of group 3 innate lymphocytes (ILC3s) - PubMed